In this Section |
256690 Repeat use of emergency contraceptive pills: A study of urban women in Kenya and NigeriaMonday, October 29, 2012
: 3:00 PM - 3:15 PM
Background
Anecdotal accounts and some research suggest that dedicated EC products are being used more frequently than intended. However, observations or even interviews with pharmacy-based ECP users over a limited time period cannot corroborate claims of repeat use, as frequent ECP users tend to be oversampled in point-of-service settings. Methods To obtain as diverse a sample of EC users as possible without conducting resource-intensive household surveys, women 18-49 years old from high, middle, and low income neighborhoods were intercepted and interviewed at high-traffic shopping areas in Nairobi, Kenya and Lagos, Nigeria. Data collection focused on the characteristics of women who use EC, patterns and extent of EC use, their contraceptive method mix, and attitudes about EC and other contraceptive methods. Results Average frequency of EC use over six months was higher among Nigerian than Kenyan women (4.6 vs. 2.1), but the context of use was similar. In Kenya, there was greater use of condoms, pills, and injectables as a main contraceptive method than in Nigeria. Nigerian women were more likely to name ECPs as their main method of contraception (41% vs. 15%) than Kenyans and their attitudes towards EC use were in line with this finding. Conclusions Results suggest that understanding repeat use is not dependent solely on the number of times a woman uses EC, but on the context of use as well. Moreover, overall contraceptive prevalence may play a role in the frequency of EC use.
Learning Areas:
Public health or related researchLearning Objectives:
Presenting author's disclosure statement:
Qualified on the content I am responsible for because: I am the Principal Investigator of the study which provides the abstract content. I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.
Back to: 3365.0: Emergency contraception: new research and new challenges
|